Robotic vs. Traditional Verticalization in Patients With Severe Acquired Brain Injury: a Randomized Controlled Trial
VEM-sABI
Multicentric Study on Combined Verticalization and Mobilization in Patients With Severe Acquired Brain Injury: A Randomized Controlled Trial
1 other identifier
interventional
118
1 country
6
Brief Summary
In the rehabilitation project for patients with severe Acquired Brain Injury (sABI), it is essential to include exercises that facilitate the recovery of the upright position (or verticalization). Recently, tilt-table equipped with the robot-assisted lower limbs cyclic mobilization has been proposed as a safe and suitable device for accelerating the adaptation to vertical posture in bedridden patients with brain-injury since the acute phase. The present multicentre study aims at evaluating the effectiveness of robotic assisted verticalization plus mobilization (VEM) versus traditional verticalization (TV) in a large cohort of patients with sABI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
Typical duration for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2024
CompletedFirst Posted
Study publicly available on registry
June 24, 2024
CompletedStudy Start
First participant enrolled
December 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
November 20, 2025
November 1, 2025
1.6 years
June 14, 2024
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Levels of cognitive functioning
A clinical scale assessing global cognitive functioning in patients emerged from a disorder of consciousness. Higher scores indicate a higher cognitive functioning
5 weeks
Secondary Outcomes (5)
Modified Ashworth scale
5 weeks - 1 month after treatment
Medical Research Council Scale
5 weeks - 1 month after treatment
modified Barthel Index
5 weeks - 1 month after treatment
Disability Rating Scale
5 weeks - 1 month after treatment
System Usability Scale
5 weeks - 1 month after treatment
Other Outcomes (9)
Spectral metrics
5 weeks - 1 month after treatment
Microstate metrics
5 weeks - 1 month after treatment
Connectivity metrics
5 weeks - 1 month after treatment
- +6 more other outcomes
Study Arms (2)
Robotic Verticalization
EXPERIMENTALErigo® gradual verticalization (from supine position up to maximum 90°, in 3 steps), depending on the patient's vital signs compliance. The Erigo verticalization is coupled with the rhythmic passive movement of the lower limbs ensuring the more normal range of motion (ROM) and the alternation of loading and unloading of the lower limbs, based on patient's osteo-articular condition (e.g., ROM=45°; cadence=min. 24 steps per minute).
Traditional Verticalization
ACTIVE COMPARATORgradual verticalization (from supine position up to maximum 90°, in 3 steps), depending on the patient's vital signs compliance, using a traditional standing device (i.e., non-robotic traditional tilt table)
Interventions
Static bed with integrated robotic stepper (ErigoBasic) and optionally integrated with Functional Electrical Stimulation (FES ErigoPro®). The Erigo is a robot designed to be used for early functional mobilisation of patients with neurological manifestations or who are bedridden, even in intensive care. It is a tilt table equipped with an integrated passive stepper controlled by microprocessors that generate physiological leg movements: the patient's thighs are secured by straps to the movement mechanisms and the feet are secured to plates equipped with shock absorbers, while the upper body is held in place by a sling integrated into the table. Erigo provides active functions: gradual elevation in orthostatism up to 90°, controlled and independent mobilisation of the lower limbs, and functional stimulation.
gradual verticalization (from supine position up to maximum 90°, in 3 steps), depending on the patient's vital signs compliance, using a traditional standing device (i.e., non-robotic traditional tilt table)
Eligibility Criteria
You may qualify if:
- Age between 18 and 75 years;
- sABI due to traumatic, vascular, anoxic, or mixed etiology;
- Stable behavioral/cognitive diagnosis on at least 4 behavioral evaluations in 1 week using the Italian version of the CRS-R in patients with pDoC, or the LCF-based cognitive assessment in patients with eDoC;
- Time post-injury between 28 days and 6 months \[1\];
- Not recovered upright station;
- Written informed consent by the patient's legal rep-resentative/primary caregiver.
You may not qualify if:
- Severe medical conditions hampering verticalization (e.g., severe hypotension or conditions realizing hemodynamic instability, end stage or severe symptomatic heart failure with reduced ejection fraction, cardiac arrhythmia of new diagnosis or arrhythmic flare, severe hepatic failure, chronic severe lower limb arterio-venous disease, sep-sis/septic shock, thrombus venous embolism of new diag-nosis, severe autonomic dysreflexia);
- Severe medical conditions hampering lower limb mobili-zation (e.g., fractures, heterotopic ossifications);
- Severe medical conditions impacting EEG activity (e.g., sub-continuous or abundant EEG epileptiform abnormali-ties);
- Severe medical conditions influencing conscious-ness/cognitive status, such as severe hyponatremia or hy-poglycemia;
- Contraindications to the use of Erigo®Basic and/or Eri-go®Pro (Hocoma, Volketswil, Switzerland) as per technical data sheet (see Appendix A);
- Presence of prohibited drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Anna Estraneolead
- Istituti Clinici Scientifici Maugeri SpAcollaborator
- Ospedale Policlinico San Martinocollaborator
Study Sites (6)
Polo Specialistico Riabilitativo Fondazione Don Carlo Gnocchi ONLUS
Sant'Angelo dei Lombardi, Avellino, 83054, Italy
IRCCS Maugeri Telese Terme
Telese Terme, BN, 82037, Italy
IRCCS "S. Maria Nascente" - Fondazione Don Gnocchi
Milan, Milan, 20148, Italy
IRCCS Maugeri Bari
Bari, 70124, Italy
Ospedale Policlinico San Martino
Genova, 16132, Italy
ICS Maugeri
Pavia, 27100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Double blind could not be applicable since a physical therapist could be blinded due to the nature of the intervention (VEM or SV). However, clinical evaluation will be performed by an examiner blind to the patient' group of treatment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Senior Researcher
Study Record Dates
First Submitted
June 14, 2024
First Posted
June 24, 2024
Study Start
December 2, 2024
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
November 20, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
A plan for wide dissemination of the results will be activated at the beginning, during and at the end of the project, through presentations at national and international conferences, and newsletters of scientific societies in the rehabilitation, neurological, and neuropsychological fields, to ensure that the results are shared with the scientific community. At the end of the project, the analysed results will be the subject of scientific publications in national and international peer-reviewed journals. The project will also be presented at regular conferences involving stakeholders (clinicians, patient and family associations) in accordance with the dissemination plan of the pnrr Fit4Med project.